Greater Cannabis Stock Revenue
| GCAN Stock | USD 0.0004 0.0001 20.00% |
Greater Cannabis fundamentals help investors to digest information that contributes to Greater Cannabis' financial success or failures. It also enables traders to predict the movement of Greater Pink Sheet. The fundamental analysis module provides a way to measure Greater Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Greater Cannabis pink sheet.
Greater |
Greater Cannabis Company Revenue Analysis
Greater Cannabis' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Greater Cannabis Revenue | 12.63 K |
Most of Greater Cannabis' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Greater Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Greater Cannabis reported 12.63 K of revenue. This is 100.0% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Greater Cannabis is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 25,260. Greater Cannabis totals roughly 12,630 in revenue claiming about 50% of equities under Drug Manufacturers—Specialty & Generic industry.Greater Fundamentals
| Return On Asset | -0.39 | |||
| Current Valuation | 688.64 K | |||
| Shares Outstanding | 668.64 M | |||
| Shares Owned By Insiders | 68.13 % | |||
| Price To Earning | 3.90 X | |||
| Price To Sales | 50.70 X | |||
| Revenue | 12.63 K | |||
| Gross Profit | (5.03 K) | |||
| EBITDA | (310.21 K) | |||
| Net Income | (602.23 K) | |||
| Cash And Equivalents | 311.2 K | |||
| Total Debt | 702.44 K | |||
| Current Ratio | 0.32 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (235.43 K) | |||
| Earnings Per Share | (0) X | |||
| Beta | 1.28 | |||
| Market Capitalization | 534.91 K | |||
| Total Asset | 392.94 K | |||
| Net Asset | 392.94 K |
About Greater Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Greater Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Greater Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Greater Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Greater Cannabis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Greater Cannabis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greater Cannabis will appreciate offsetting losses from the drop in the long position's value.Moving together with Greater Pink Sheet
Moving against Greater Pink Sheet
The ability to find closely correlated positions to Greater Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Greater Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Greater Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Greater Cannabis to buy it.
The correlation of Greater Cannabis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Greater Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Greater Cannabis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Greater Cannabis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Greater Pink Sheet
Greater Cannabis financial ratios help investors to determine whether Greater Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Greater with respect to the benefits of owning Greater Cannabis security.